University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital San Francisco
Search Site | Find a Doctor

Peter Goadsby, M.B. B.S.

Neurologist and headache specialist

Dr. Peter Goadsby, a neurologist, specializes in the diagnosis and treatment of headache disorders, including migraines and cluster headache and other forms of chronic daily headache. He is one of the world's leading headache experts and researchers.

Goadsby came to UCSF from the Institute of Neurology at University College London, National Hospital for Neurology and Neurosurgery and Hospital for Sick Children, Great Ormond Street, London, England. His research focuses on the mechanisms and management of head pain, with a special interest in migraine and trigeminal autonomic cephalalgias. His studies aim to understand the parts of the brain involved in headache and from this to derive new approaches to treatment. He earned a medical degree at the University of New South Wales School of Medicine, completed a residency in neurology at the Prince of Wales Hospital and completed a fellowship in neurology at the National Hospital for Nervous and Mental Diseases in London. He completed post-doctoral work in laboratories in New York and Paris.


Headache Center
2330 Post St., Sixth Floor
San Francisco, CA 94115
Phone: (415) 353-8393
Fax: (415) 353-9539

Hours: Monday to Friday
9 a.m. – 5 p.m.

Conditions & Treatments

More about Peter Goadsby


University of New South Wales Doctorate Program, Neurosciences 1983
University of New South Wales School of Medicine 1985


Prince Henry, Prince of Wales Hospital, Medicine 1987
Prince Henry, Prince of Wales Hospital, Neurology 1988
Prince Henry, Prince of Wales Hospital, Clinical Neurophysiology 1989


National Hospital for Nervous and Mental Diseases, Neurology 1990

Selected Research and Publications

  1. Diener HC, Charles A, Goadsby PJ, Holle D. New therapeutic approaches for the prevention and treatment of migraine. Lancet Neurol. 2015 Oct; 14(10):1010-22.
  2. Goadsby PJ. Unique Migraine Subtypes, Rare Headache Disorders, and Other Disturbances. Continuum (Minneap Minn). 2015 Aug; 21(4 Headache):1032-40.
  3. Bhola R, Kinsella E, Giffin N, Lipscombe S, Ahmed F, Weatherall M, Goadsby PJ. Single-pulse transcranial magnetic stimulation (sTMS) for the acute treatment of migraine: evaluation of outcome data for the UK post market pilot program. J Headache Pain. 2015 Dec; 16(1):535.
  4. Karsan N, Goadsby PJ. Calcitonin gene-related peptide and migraine. Curr Opin Neurol. 2015 Jun; 28(3):250-4.
  5. Tso AR, Goadsby PJ. Recent neuroimaging advances in the study of primary headaches. Curr Pain Headache Rep. 2015 Jun; 19(6):487.
  6. Schankin CJ, Goadsby PJ. Visual snow-persistent positive visual phenomenon distinct from migraine aura. Curr Pain Headache Rep. 2015 Jun; 19(6):497.
  7. Gantenbein AR, Sarikaya H, Riederer F, Goadsby PJ. Postoperative hemicrania continua-like headache - a case series. J Headache Pain. 2015 Dec; 16(1):526.
  8. Goadsby PJ. Comment: How do triptans work in migraine? Neurology. 2015 May 26; 84(21):2129.
  9. Karsan N, Goadsby PJ. CGRP mechanism antagonists and migraine management. Curr Neurol Neurosci Rep. 2015 May; 15(5):547.
  10. Maniyar FH, Sprenger T, Monteith T, Schankin CJ, Goadsby PJ. The premonitory phase of migraine - what can we learn from it? Headache. 2015 May; 55(5):609-20.
  11. Hansen JM, Goadsby PJ, Charles A. Reduced efficacy of sumatriptan in migraine with aura vs without aura. Neurology. 2015 May 5; 84(18):1880-5.
  12. Andreou AP, Holland PR, Lasalandra MP, Goadsby PJ. Modulation of nociceptive dural input to the trigeminocervical complex through GluK1 kainate receptors. Pain. 2015 Mar; 156(3):439-50.
  13. Nesbitt AD, Marin JC, Tompkins E, Ruttledge MH, Goadsby PJ. Initial use of a novel noninvasive vagus nerve stimulator for cluster headache treatment. Neurology. 2015 Mar 24; 84(12):1249-53.
  14. Tso AR, Trujillo A, Guo CC, Goadsby PJ, Seeley WW. The anterior insula shows heightened interictal intrinsic connectivity in migraine without aura. Neurology. 2015 Mar 10; 84(10):1043-50.
  15. Goadsby PJ. Putting migraine to sleep: Rexants as a preventive strategy. Cephalalgia. 2015 Apr; 35(5):377-8.
  16. Dodick DW, Goadsby PJ, Spierings EL, Scherer JC, Sweeney SP, Grayzel DS. Site of effect of LY2951742 for migraine prophylaxis-Authors' reply. Lancet Neurol. 2015 Jan; 14(1):32-3.
  17. Akerman S, Goadsby PJ. A novel translational animal model of trigeminal autonomic cephalalgias. Headache. 2015 Jan; 55(1):197-203.
  18. Maniyar FH, Sprenger T, Schankin C, Goadsby PJ. The origin of nausea in migraine-A PET study. J Headache Pain. 2014; 15:84.
  19. Zagami AS, Edvinsson L, Goadsby PJ. Pituitary adenylate cyclase activating polypeptide and migraine. Ann Clin Transl Neurol. 2014 Dec; 1(12):1036-40.
  20. Hoffmann J, Supronsinchai W, Akerman S, Andreou AP, Winrow CJ, Renger J, Hargreaves R, Goadsby PJ. Evidence for orexinergic mechanisms in migraine. Neurobiol Dis. 2015 Feb; 74:137-43.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.